Serum levels of IL-6 in adult patients with moderate to severe asthma.

D. Dimitrova (SOFIA, Bulgaria)

Source: International Congress 2017 – Novel mechanisms in asthma
Session: Novel mechanisms in asthma
Session type: Thematic Poster
Number: 1166
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Dimitrova (SOFIA, Bulgaria). Serum levels of IL-6 in adult patients with moderate to severe asthma.. 1166

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020


Serum Interleukin (IL)-6 levels in patients with severe asthma disease is associated with blood eosinophilia
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Year: 2005

Serum levels of IL-5, IL-6 and IL-8 in moderate and severe asthma clusters
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018



Serum levels of IL-8 is related to airflow limitation in mild and severe asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 548s
Year: 2003

Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 424s
Year: 2002

Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 353s
Year: 2004

Serum leptin levels in patients with chronic airway diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 306s
Year: 2005

Serum IL-12p70 and IL-12p40 levels in severe asthma patients with fixed airway obstruction
Source: Eur Respir J 2006; 28: Suppl. 50, 234s
Year: 2006

Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Serum levels of interleukin-18 in patients affected by allergic bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 30s
Year: 2002

Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012

Serum neopterin and IL-6 as biomarkers in patients with COPD.
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017


Cytokine plasma levels in moderate-to-severe asthmatic children with different asthma control
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Serum TNFα and IL8 as markers of systemic inflammation in severe asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Year: 2005

Inflammatory cytokines in serum from children with severe asthma compared to controlled asthmatics
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012

Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017